| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Abnormal Hyperphosphorylation of Tau: Sites, Regulation, and Molecular Mechanism of Neurofibrillary Degeneration
|
Wang, Jian-Zhi
|
|
2012
|
|
supplement-1 |
p. S123-S139
|
artikel
|
| 2 |
Abnormal Mitochondrial Dynamics in the Pathogenesis of Alzheimer's Disease
|
Zhu, Xiongwei
|
|
2012
|
|
supplement-1 |
p. S253-S262
|
artikel
|
| 3 |
A Brief History of Alzheimer's Disease Gene Discovery
|
Tanzi, Rudolph E.
|
|
2012
|
|
supplement-1 |
p. S5-S13
|
artikel
|
| 4 |
AD Gene 3-D: Moving Past Single Layer Genetic Information to Map Novel Loci Involved in Alzheimer's Disease
|
Myers, Amanda J.
|
|
2012
|
|
supplement-1 |
p. S15-S22
|
artikel
|
| 5 |
Alzheimer's Disease: Advances for a New Century
|
Perry, George
|
|
2013
|
|
supplement-1 |
p. S1
|
artikel
|
| 6 |
Alzheimer's Disease and the Frontotemporal Dementias: Contributions to Clinico-Pathological Studies, Diagnosis, and Cognitive Neuroscience
|
Hodges, John R.
|
|
2012
|
|
supplement-1 |
p. S211-S217
|
artikel
|
| 7 |
Alzheimer's Disease and the Quest for its Biological Measures
|
Praticò, Domenico
|
|
2012
|
|
supplement-1 |
p. S237-S241
|
artikel
|
| 8 |
Alzheimer's Disease and the “Valley of Death”: Not Enough Guidance from Human Brain Tissue?
|
Beach, Thomas G.
|
|
2012
|
|
supplement-1 |
p. S219-S233
|
artikel
|
| 9 |
Alzheimer's Disease: Recent Advances and Future Perspectives
|
Ubhi, Kiren
|
|
2012
|
|
supplement-1 |
p. S185-S194
|
artikel
|
| 10 |
Alzheimer's Disease-Related Lesions
|
Alafuzoff, Irina
|
|
2012
|
|
supplement-1 |
p. S173-S179
|
artikel
|
| 11 |
Amyloid-β and Cognition in Aging and Alzheimer's Disease: Molecular and Neurophysiological Mechanisms
|
Hampel, Harald
|
|
2012
|
|
supplement-1 |
p. S79-S86
|
artikel
|
| 12 |
Amyloid-β Peptide: Dr. Jekyll or Mr. Hyde?
|
Puzzo, Daniela
|
|
2012
|
|
supplement-1 |
p. S111-S120
|
artikel
|
| 13 |
Anatomic and Clinical Pathology of Cognitive Impairment and Dementia
|
Montine, Kathleen S.
|
|
2012
|
|
supplement-1 |
p. S181-S184
|
artikel
|
| 14 |
Argyrophilic Grain Pathology as a Natural Model of Tau Propagation
|
Rábano, Alberto
|
|
2014
|
|
supplement-1 |
p. S123-S133
|
artikel
|
| 15 |
Biomarkers for Alzheimer's Disease: Showing the Way or Leading Us Astray?
|
Quinn, Joseph F.
|
|
2012
|
|
supplement-1 |
p. S371-S376
|
artikel
|
| 16 |
Brain Structural and Functional Connectivity and the Progression of Neuropathology in Alzheimer's Disease
|
Matthews, Paul M.
|
|
2012
|
|
supplement-1 |
p. S163-S172
|
artikel
|
| 17 |
Caffeine, Adenosine Receptors, and Synaptic Plasticity
|
Costenla, Ana Rita
|
|
2010
|
|
supplement-1 |
p. 25-34
|
artikel
|
| 18 |
Caffeine and Adenosine
|
Ribeiro, Joaquim A.
|
|
2010
|
|
supplement-1 |
p. 3-15
|
artikel
|
| 19 |
Caffeine and Coffee as Therapeutics Against Alzheimer's Disease
|
Arendash, Gary W.
|
|
2010
|
|
supplement-1 |
p. 117-126
|
artikel
|
| 20 |
Caffeine and Cognition in Functional Magnetic Resonance Imaging
|
Koppelstaetter, Florian
|
|
2010
|
|
supplement-1 |
p. 71-84
|
artikel
|
| 21 |
Caffeine and the Control of Cerebral Hemodynamics
|
Pelligrino, Dale A.
|
|
2010
|
|
supplement-1 |
p. 51-62
|
artikel
|
| 22 |
Caffeine as a Protective Factor in Dementia and Alzheimer's Disease
|
Eskelinen, Marjo H.
|
|
2010
|
|
supplement-1 |
p. 167-174
|
artikel
|
| 23 |
Caffeine, Cognition, and Socioeconomic Status
|
Kyle, Janet
|
|
2010
|
|
supplement-1 |
p. 151-159
|
artikel
|
| 24 |
Caffeine, Cognitive Functioning, and White Matter Lesions in the Elderly: Establishing Causality from Epidemiological Evidence
|
Ritchie, Karen
|
|
2010
|
|
supplement-1 |
p. 161-166
|
artikel
|
| 25 |
Caffeine, Diabetes, Cognition, and Dementia
|
Biessels, Geert Jan
|
|
2010
|
|
supplement-1 |
p. 143-150
|
artikel
|
| 26 |
Caffeine Exposure and the Risk of Parkinson's Disease: A Systematic Review and Meta-Analysis of Observational Studiess
|
Costa, João
|
|
2010
|
|
supplement-1 |
p. 221-238
|
artikel
|
| 27 |
Caffeine Intake and Dementia: Systematic Review and Meta-Analysis
|
Santos, Catarina
|
|
2010
|
|
supplement-1 |
p. 187-204
|
artikel
|
| 28 |
Caffeine Intake is Associated with a Lower Risk of Cognitive Decline: A Cohort Study from Portugal
|
Santos, Catarina
|
|
2010
|
|
supplement-1 |
p. 175-185
|
artikel
|
| 29 |
Caffeine, Mental Health, and Psychiatric Disorders
|
Lara, Diogo R.
|
|
2010
|
|
supplement-1 |
p. 239-248
|
artikel
|
| 30 |
Caffeine Protects Against Disruptions of the Blood-Brain Barrier in Animal Models of Alzheimer's and Parkinson's Diseases
|
Chen, Xuesong
|
|
2010
|
|
supplement-1 |
p. 127-141
|
artikel
|
| 31 |
Cerebrospinal Fluid Biomarkers for Alzheimer's Disease: More to Come?
|
Zetterberg, Henrik
|
|
2012
|
|
supplement-1 |
p. S361-S369
|
artikel
|
| 32 |
Characterizing the Preclinical Stages of Alzheimer's Disease and the Prospect of Presymptomatic Intervention
|
Caselli, Richard J.
|
|
2012
|
|
supplement-1 |
p. S405-S416
|
artikel
|
| 33 |
Chronic Caffeine Consumption Prevents Memory Disturbance in Different Animal Models of Memory Decline
|
Cunha, Rodrigo A.
|
|
2010
|
|
supplement-1 |
p. 95-116
|
artikel
|
| 34 |
Clinically Asymptomatic Vascular Brain Injury: A Potent Cause of Cognitive Impairment Among Older Individuals
|
DeCarli, Charles
|
|
2012
|
|
supplement-1 |
p. S417-S426
|
artikel
|
| 35 |
Concluding Remarks
|
Mendonça, Alexandre
|
|
2010
|
|
supplement-1 |
p. 249-252
|
artikel
|
| 36 |
Crosstalk between Axonal Classical Microtubule-Associated Proteins and End Binding Proteins during Axon Extension: Possible Implications in Neurodegeneration
|
Sayas, C.L.
|
|
2014
|
|
supplement-1 |
p. S17-S22
|
artikel
|
| 37 |
Effects of Caffeine in Parkinson's Disease: From Neuroprotection to the Management of Motor and Non-Motor Symptoms
|
Prediger, Rui D.S.
|
|
2010
|
|
supplement-1 |
p. 205-220
|
artikel
|
| 38 |
Electrophysiological Studies in Healthy Subjects Involving Caffeine
|
de Carvalho, Mamede
|
|
2010
|
|
supplement-1 |
p. 63-69
|
artikel
|
| 39 |
Elucidating the Triggers, Progression, and Effects of Alzheimer's Disease
|
Medeiros, Rodrigo
|
|
2012
|
|
supplement-1 |
p. S195-S210
|
artikel
|
| 40 |
Endothelin-Converting Enzymes and Related Metalloproteases in Alzheimer's Disease
|
Pacheco-Quinto, Javier
|
|
2012
|
|
supplement-1 |
p. S101-S110
|
artikel
|
| 41 |
Evolutional Aspects of Alzheimer's Disease Pathogenesis
|
Braak, Heiko
|
|
2012
|
|
supplement-1 |
p. S155-S161
|
artikel
|
| 42 |
From Genetics to Dietetics: The Contribution of Epidemiology to Understanding Alzheimer's Disease
|
Barberger-Gateau, Pascale
|
|
2012
|
|
supplement-1 |
p. S457-S463
|
artikel
|
| 43 |
From Molecule to Clinic and Community for Neurodegeneration: Research to Bridge Translational Gaps
|
Brayne, Carol
|
|
2012
|
|
supplement-1 |
p. S385-S396
|
artikel
|
| 44 |
GSK3 and Tau: Two Convergence Points in Alzheimer's Disease
|
Hernandez, Felix
|
|
2012
|
|
supplement-1 |
p. S141-S144
|
artikel
|
| 45 |
Harnessing the Immune System for Treatment and Detection of Tau Pathology
|
Congdon, Erin E.
|
|
2014
|
|
supplement-1 |
p. S113-S121
|
artikel
|
| 46 |
Imaging the Onset and Progression of Alzheimer's Disease: Implications for Prevention Trials
|
Liang, Yuying
|
|
2012
|
|
supplement-1 |
p. S305-S312
|
artikel
|
| 47 |
Insulin and Alzheimer's Disease: Untangling the Web
|
Craft, Suzanne
|
|
2012
|
|
supplement-1 |
p. S263-S275
|
artikel
|
| 48 |
Intracellular and Extracellular Roles for Tau in Neurodegenerative Disease
|
Hanger, Diane P.
|
|
2014
|
|
supplement-1 |
p. S37-S45
|
artikel
|
| 49 |
Iron dysregulation and Parkinson's disease
|
Julie K. Andersen
|
|
2005
|
|
supplement-1 |
p. S47-S52
|
artikel
|
| 50 |
Is Caffeine a Cognitive Enhancer?
|
Nehlig, Astrid
|
|
2010
|
|
supplement-1 |
p. 85-94
|
artikel
|
| 51 |
Is Tau a Prion-Like Protein?
|
Medina, Miguel
|
|
2014
|
|
supplement-1 |
p. S1-S3
|
artikel
|
| 52 |
Lessons from Epidemiologic Research about Risk Factors, Modifiers, and Progression of Late Onset Alzheimer's Disease in New York City at Columbia University Medical Center
|
Devanand, Devangere
|
|
2012
|
|
supplement-1 |
p. S447-S455
|
artikel
|
| 53 |
Lester (Skip) Binder (1949-2013): In the Beginning was Tau
|
Brinkley, William R.
|
|
2014
|
|
supplement-1 |
p. S5
|
artikel
|
| 54 |
Longitudinal Assessment of a Transgenic Animal Model of Tauopathy by FDG-PET Imaging
|
de Cristóbal, Javier
|
|
2014
|
|
supplement-1 |
p. S79-S89
|
artikel
|
| 55 |
Long Night's Journey into the Day: Amyloid-β Imaging in Alzheimer's Disease
|
Villemagne, Victor L.
|
|
2012
|
|
supplement-1 |
p. S349-S359
|
artikel
|
| 56 |
Metals, Membranes, and Amyloid-β Oligomers: Key Pieces in the Alzheimer's Disease Puzzle?
|
Watt, Andrew D.
|
|
2012
|
|
supplement-1 |
p. S283-S293
|
artikel
|
| 57 |
Molecular Mechanisms of Amyloid Oligomers Toxicity
|
Kayed, Rakez
|
|
2012
|
|
supplement-1 |
p. S67-S78
|
artikel
|
| 58 |
Multimodal Comparative Studies of Neurodegenerative Diseases
|
Grossman, Murray
|
|
2012
|
|
supplement-1 |
p. S379-S383
|
artikel
|
| 59 |
Neurogenesis as a potential therapeutic strategy for neurodegenerative disorders
|
J. Kelleher-Andersson
|
|
2005
|
|
supplement-1 |
p. S19-S25
|
artikel
|
| 60 |
Neurotrophin-based strategies for neuroprotection
|
Frank M. Longo
|
|
2005
|
|
supplement-1 |
p. S13-S17
|
artikel
|
| 61 |
Neurotrophin survival signaling mechanisms
|
Moses V. Chao
|
|
2005
|
|
supplement-1 |
p. S7-S11
|
artikel
|
| 62 |
Neurovascular Defects and Faulty Amyloid-β Vascular Clearance in Alzheimer's Disease
|
Sagare, Abhay P.
|
|
2012
|
|
supplement-1 |
p. S87-S100
|
artikel
|
| 63 |
New directions in neuroprotection: Basic mechanisms, molecular targets and treatment strategies
|
L.M. Refolo
|
|
2005
|
|
supplement-1 |
p. S1-S2
|
artikel
|
| 64 |
Novel analogs of choline as potential neuroprotective agents
|
Jerry J. Buccafusco
|
|
2005
|
|
supplement-1 |
p. S85-S92
|
artikel
|
| 65 |
Novel nitrates as NO mimetics directed at Alzheimer's disease
|
Gregory R.J. Thatcher
|
|
2005
|
|
supplement-1 |
p. S75-S84
|
artikel
|
| 66 |
Novel small peptides with neuroprotective and nootropic properties
|
Alan I. Faden
|
|
2005
|
|
supplement-1 |
p. S93-S97
|
artikel
|
| 67 |
Novel Tubulin and Tau Neuroprotective Fragments Sharing Structural Similarities with the Drug Candidate NAP (Davuentide)
|
Gozes, Illana
|
|
2014
|
|
supplement-1 |
p. S23-S36
|
artikel
|
| 68 |
Oxidative Modification of Brain Proteins in Alzheimer's Disease: Perspective on Future Studies Based on Results of Redox Proteomics Studies
|
Sultana, Rukhsana
|
|
2012
|
|
supplement-1 |
p. S243-S251
|
artikel
|
| 69 |
Paradigm shift in NMDA receptor antagonist drug development: Molecular mechanism of uncompetitive inhibition by memantine in the treatment of Alzheimer's disease and other neurologic disorders
|
Stuart A. Lipton
|
|
2005
|
|
supplement-1 |
p. S61-S74
|
artikel
|
| 70 |
Patterns of Compensation and Vulnerability in Normal Subjects at Risk of Alzheimer's Disease
|
Lopez, Oscar L.
|
|
2012
|
|
supplement-1 |
p. S427-S438
|
artikel
|
| 71 |
Perspectives for Multimodal Neurochemical and Imaging Biomarkers in Alzheimer's Disease
|
Teipel, Stefan J.
|
|
2012
|
|
supplement-1 |
p. S329-S347
|
artikel
|
| 72 |
Prevention of Alzheimer's Disease: Moving Backward through the Lifespan
|
Solomon, Alina
|
|
2012
|
|
supplement-1 |
p. S465-S469
|
artikel
|
| 73 |
Proteins Recruited to Exosomes by Tau Overexpression Implicate Novel Cellular Mechanisms Linking Tau Secretion with Alzheimer's Disease
|
Saman, Sudad
|
|
2014
|
|
supplement-1 |
p. S47-S70
|
artikel
|
| 74 |
Quantifying Age-Related Myelin Breakdown with MRI: Novel Therapeutic Targets for Preventing Cognitive Decline and Alzheimer's Disease
|
George Bartzokis
|
|
2005
|
|
supplement-1 |
p. S53-S59
|
artikel
|
| 75 |
Recent Advances in Imaging Alzheimer's Disease
|
Braskie, Meredith N.
|
|
2012
|
|
supplement-1 |
p. S313-S327
|
artikel
|
| 76 |
Redefining neuroprotective gene therapeutic strategies: Lessons learned from caloric restriction and NAD^+ metabolism
|
L.A. Henricksen
|
|
2005
|
|
supplement-1 |
p. S43-S46
|
artikel
|
| 77 |
Requirements of a brain selective estrogen: Advances and remaining challenges for developing a NeuroSERM
|
Roberta Diaz Brinton
|
|
2005
|
|
supplement-1 |
p. S27-S35
|
artikel
|
| 78 |
Risk Estimations, Risk Factors, and Genetic Variants Associated with Alzheimer's Disease in Selected Publications from the Framingham Heart Study
|
Weinstein, Galit
|
|
2012
|
|
supplement-1 |
p. S439-S445
|
artikel
|
| 79 |
Role of the Central Ascending Neurotransmitter Systems in the Psychostimulant Effects of Caffeine
|
Ferré, Sergi
|
|
2010
|
|
supplement-1 |
p. 35-49
|
artikel
|
| 80 |
Selected Findings from the Religious Orders Study and Rush Memory and Aging Project
|
Bennett, David A.
|
|
2012
|
|
supplement-1 |
p. S397-S403
|
artikel
|
| 81 |
Sources of Extracellular Tau and its Signaling
|
Avila, Jesús
|
|
2014
|
|
supplement-1 |
p. S7-S15
|
artikel
|
| 82 |
Specific Targeting of Tau Oligomers in Htau Mice Prevents Cognitive Impairment and Tau Toxicity Following Injection with Brain-Derived Tau Oligomeric Seeds
|
Castillo-Carranza, Diana L.
|
|
2014
|
|
supplement-1 |
p. S97-S111
|
artikel
|
| 83 |
Synaptotoxic Amyloid-β Oligomers: A Molecular Basis for the Cause, Diagnosis, and Treatment of Alzheimer's Disease?
|
Klein, William L.
|
|
2012
|
|
supplement-1 |
p. S49-S65
|
artikel
|
| 84 |
TARDBP Mutation Analysis in TDP-43 Proteinopathies and Deciphering the Toxicity of Mutant TDP-43
|
Gendron, Tania F.
|
|
2012
|
|
supplement-1 |
p. S35-S45
|
artikel
|
| 85 |
Tau Oligomers as Potential Targets for Early Diagnosis of Tauopathy
|
Sahara, Naruhiko
|
|
2014
|
|
supplement-1 |
p. S91-S96
|
artikel
|
| 86 |
Tau Triage Decisions Mediated by the Chaperone Network
|
Cook, Casey
|
|
2012
|
|
supplement-1 |
p. S145-S151
|
artikel
|
| 87 |
Tau Triggers Tear Secretion by Interacting with Muscarinic Acetylcholine Receptors in New Zealand White Rabbits
|
Martinez-Aguila, Alejandro
|
|
2014
|
|
supplement-1 |
p. S71-S77
|
artikel
|
| 88 |
The femtomolar-acting NAP interacts with microtubules: Novel aspects of astrocyte protection
|
Illana Gozes
|
|
2005
|
|
supplement-1 |
p. S37-S41
|
artikel
|
| 89 |
The Metal Theory of Alzheimer's Disease
|
Bush, Ashley I.
|
|
2012
|
|
supplement-1 |
p. S277-S281
|
artikel
|
| 90 |
The NeuroImmune System in Alzheimer's Disease: The Glass is Half Full
|
Hickman, Suzanne E.
|
|
2012
|
|
supplement-1 |
p. S295-S302
|
artikel
|
| 91 |
Therapeutic Opportunities for Caffeine in Alzheimer's Disease and Other Neurodegenerative Disorders
|
Mendonça, Alexandre
|
|
2010
|
|
supplement-1 |
p. 1-2
|
artikel
|
| 92 |
Toward a mechanistic taxonomy of cell death programs
|
Dale E. Bredesen
|
|
2005
|
|
supplement-1 |
p. S3-S6
|
artikel
|
| 93 |
Trait, State, and Mechanism: Looking Back, Looking Forward, and Understanding Why
|
Lovestone, Simon
|
|
2012
|
|
supplement-1 |
p. S23-S33
|
artikel
|
| 94 |
Vaccination with Sarkosyl Insoluble PHF-Tau Decrease Neurofibrillary Tangles Formation in Aged Tau Transgenic Mouse Model: A Pilot Study
|
Ando, Kunie
|
|
2014
|
|
supplement-1 |
p. S135-S145
|
artikel
|
| 95 |
VII Congresso Sindem: Italian Association for the study of Dementia linked to the Italian Neurological Society (SIN)
|
Bonavita, Vincenzo
|
|
2012
|
|
supplement-1 |
p. 1-109
|
artikel
|
| 96 |
VI Sindem MEETING: Italian Association for the Study of Dementia linked to the Italian Neurological Society (SIN)
|
Bonavita, Vincenzo
|
|
2011
|
|
supplement-1 |
p. S1-S87
|
artikel
|
| 97 |
What Knock-Out Animals Tell Us About the Effects of Caffeine
|
Chen, Jiang-Fan
|
|
2010
|
|
supplement-1 |
p. 17-24
|
artikel
|
Tijdschrift beschrijving